Melovem

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
19-06-2014
Ciri produk Ciri produk (SPC)
19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
10-10-2013

Bahan aktif:

meloxicam

Boleh didapati daripada:

Dopharma Research B.V.

Kod ATC:

QM01AC06

INN (Nama Antarabangsa):

meloxicam

Kumpulan terapeutik:

Pigs; Calves

Kawasan terapeutik:

Oxicams

Tanda-tanda terapeutik:

CattleFor use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle. For use in diarrhoea in combination with oral rehydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle. For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.PigsFor use in noninfectious locomotor disorders to reduce the symptoms of lameness and inflammation. For the relief of postoperative pain associated with minor soft-tissue surgery such as castration. For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.HorsesFor use in the alleviation of inflammation and relief of pain in both acute and chronic musculoskeletal disorders. For the relief of pain associated with equine colic.

Ringkasan produk:

Revision: 5

Status kebenaran:

Authorised

Tarikh kebenaran:

2009-07-07

Risalah maklumat

                                35
B. PACKAGE LEAFLET
36
PACKAGE LEAFLET FOR:
Melovem 5 mg/ml solution for injection for cattle and pigs
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF
THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
RELEASE, IF DIFFERENT
Marketing authorisation holder:
Dopharma Research B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
Manufacturer responsible for batch release:
Dopharma B.V.
Zalmweg 24
4941 VX Raamsdonksveer The Netherlands
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
Meloxicam
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
A clear, greenish yellow solution.
4.
INDICATION(S)
CATTLE:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
PIGS:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
5.
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
37
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
6.
ADVERSE REACTIONS
Transient swelling at the injection site was commonly reported in
clinical studies following
subcutaneous administration in cattle. Injection site swelling may be
painful.
Transient swelling at the injection site was observed in clinical
studies following intramuscu
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Melovem 5 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Meloxicam 5 mg
EXCIPIENT(S):
Benzyl alcohol 50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, greenish yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves and young cattle) and pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle:
For use in acute respiratory infection with appropriate antibiotic
therapy to reduce clinical signs in
cattle.
For use in diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of
over one week of age and young, non-lactating cattle.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms
of lameness and inflammation.
For the relief of post operative pain associated with minor soft
tissue surgery such as castration.
4.3
CONTRAINDICATIONS
Do not use in animals suffering from impaired hepatic, cardiac or
renal function and haemorrhagic
disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in case of hypersensitivity to the active substance or to
any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals of
less than one week of age.
Do not use in pigs less than 2 days old.
3
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of calves with Melovem 20 minutes before dehorning reduces
post-operative pain.
Melovem alone will not provide adequate pain relief during the
dehorning procedure. To obtain
adequate pain relief during surgery co-medication with an appropriate
analgesic is needed.
Treatment of piglets with Melovem before castration reduces post
operative pain. To obtain pain relief
during surgery co-medication with an appropriate anaesthetic/sedative
is needed.
To obtain the
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 19-06-2014
Ciri produk Ciri produk Bulgaria 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 10-10-2013
Risalah maklumat Risalah maklumat Sepanyol 19-06-2014
Ciri produk Ciri produk Sepanyol 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 10-10-2013
Risalah maklumat Risalah maklumat Czech 19-06-2014
Ciri produk Ciri produk Czech 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Czech 10-10-2013
Risalah maklumat Risalah maklumat Denmark 19-06-2014
Ciri produk Ciri produk Denmark 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 10-10-2013
Risalah maklumat Risalah maklumat Jerman 19-06-2014
Ciri produk Ciri produk Jerman 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 10-10-2013
Risalah maklumat Risalah maklumat Estonia 19-06-2014
Ciri produk Ciri produk Estonia 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 10-10-2013
Risalah maklumat Risalah maklumat Greek 19-06-2014
Ciri produk Ciri produk Greek 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Greek 10-10-2013
Risalah maklumat Risalah maklumat Perancis 19-06-2014
Ciri produk Ciri produk Perancis 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 10-10-2013
Risalah maklumat Risalah maklumat Itali 19-06-2014
Ciri produk Ciri produk Itali 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Itali 10-10-2013
Risalah maklumat Risalah maklumat Latvia 19-06-2014
Ciri produk Ciri produk Latvia 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 10-10-2013
Risalah maklumat Risalah maklumat Lithuania 19-06-2014
Ciri produk Ciri produk Lithuania 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 10-10-2013
Risalah maklumat Risalah maklumat Hungary 19-06-2014
Ciri produk Ciri produk Hungary 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 10-10-2013
Risalah maklumat Risalah maklumat Malta 19-06-2014
Ciri produk Ciri produk Malta 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Malta 10-10-2013
Risalah maklumat Risalah maklumat Belanda 19-06-2014
Ciri produk Ciri produk Belanda 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 10-10-2013
Risalah maklumat Risalah maklumat Poland 19-06-2014
Ciri produk Ciri produk Poland 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Poland 10-10-2013
Risalah maklumat Risalah maklumat Portugis 19-06-2014
Ciri produk Ciri produk Portugis 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 10-10-2013
Risalah maklumat Risalah maklumat Romania 19-06-2014
Ciri produk Ciri produk Romania 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Romania 10-10-2013
Risalah maklumat Risalah maklumat Slovak 19-06-2014
Ciri produk Ciri produk Slovak 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 10-10-2013
Risalah maklumat Risalah maklumat Slovenia 19-06-2014
Ciri produk Ciri produk Slovenia 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 10-10-2013
Risalah maklumat Risalah maklumat Finland 19-06-2014
Ciri produk Ciri produk Finland 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Finland 10-10-2013
Risalah maklumat Risalah maklumat Sweden 19-06-2014
Ciri produk Ciri produk Sweden 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 10-10-2013
Risalah maklumat Risalah maklumat Norway 19-06-2014
Ciri produk Ciri produk Norway 19-06-2014
Risalah maklumat Risalah maklumat Iceland 19-06-2014
Ciri produk Ciri produk Iceland 19-06-2014
Risalah maklumat Risalah maklumat Croat 19-06-2014
Ciri produk Ciri produk Croat 19-06-2014
Laporan Penilaian Awam Laporan Penilaian Awam Croat 10-10-2013

Cari amaran yang berkaitan dengan produk ini

Lihat sejarah dokumen